These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 22446161)

  • 1. Reduction of heart failure by pharmacological inhibition or gene deletion of protein tyrosine phosphatase 1B.
    Gomez E; Vercauteren M; Kurtz B; Ouvrard-Pascaud A; Mulder P; Henry JP; Besnier M; Waget A; Hooft Van Huijsduijnen R; Tremblay ML; Burcelin R; Thuillez C; Richard V
    J Mol Cell Cardiol; 2012 Jun; 52(6):1257-64. PubMed ID: 22446161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene deletion of protein tyrosine phosphatase 1B protects against sepsis-induced cardiovascular dysfunction and mortality.
    Coquerel D; Neviere R; Delile E; Mulder P; Marechal X; Montaigne D; Renet S; Remy-Jouet I; Gomez E; Henry JP; do Rego JC; Richard V; Tamion F
    Arterioscler Thromb Vasc Biol; 2014 May; 34(5):1032-44. PubMed ID: 24578383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein tyrosine phosphatase 1B inactivation limits aging-associated heart failure in mice.
    Besnier M; Coquerel D; Favre J; Dumesnil A; Guerrot D; Remy-Jouet I; Mulder P; Djerada Z; Tamion F; Richard V; Ouvrard-Pascaud A
    Am J Physiol Heart Circ Physiol; 2018 Jun; 314(6):H1279-H1288. PubMed ID: 29569957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective Vascular Endothelial Protection Reduces Cardiac Dysfunction in Chronic Heart Failure.
    Maupoint J; Besnier M; Gomez E; Bouhzam N; Henry JP; Boyer O; Nicol L; Mulder P; Martinet J; Richard V
    Circ Heart Fail; 2016 Apr; 9(4):e002895. PubMed ID: 27059805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improvement of peripheral endothelial dysfunction by protein tyrosine phosphatase inhibitors in heart failure.
    Vercauteren M; Remy E; Devaux C; Dautreaux B; Henry JP; Bauer F; Mulder P; Hooft van Huijsduijnen R; Bombrun A; Thuillez C; Richard V
    Circulation; 2006 Dec; 114(23):2498-507. PubMed ID: 17101854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced angiogenesis and increased cardiac perfusion after myocardial infarction in protein tyrosine phosphatase 1B-deficient mice.
    Besnier M; Galaup A; Nicol L; Henry JP; Coquerel D; Gueret A; Mulder P; Brakenhielm E; Thuillez C; Germain S; Richard V; Ouvrard-Pascaud A
    FASEB J; 2014 Aug; 28(8):3351-61. PubMed ID: 24760754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelial deletion of protein tyrosine phosphatase-1B protects against pressure overload-induced heart failure in mice.
    Gogiraju R; Schroeter MR; Bochenek ML; Hubert A; Münzel T; Hasenfuss G; Schäfer K
    Cardiovasc Res; 2016 Aug; 111(3):204-16. PubMed ID: 27207947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soluble epoxide hydrolase inhibition improves myocardial perfusion and function in experimental heart failure.
    Merabet N; Bellien J; Glevarec E; Nicol L; Lucas D; Remy-Jouet I; Bounoure F; Dreano Y; Wecker D; Thuillez C; Mulder P
    J Mol Cell Cardiol; 2012 Mar; 52(3):660-6. PubMed ID: 22155238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improvement in left ventricular remodeling by the endothelial nitric oxide synthase enhancer AVE9488 after experimental myocardial infarction.
    Fraccarollo D; Widder JD; Galuppo P; Thum T; Tsikas D; Hoffmann M; Ruetten H; Ertl G; Bauersachs J
    Circulation; 2008 Aug; 118(8):818-27. PubMed ID: 18678774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of NADPH oxidase reduces myocardial oxidative stress and apoptosis and improves cardiac function in heart failure after myocardial infarction.
    Qin F; Simeone M; Patel R
    Free Radic Biol Med; 2007 Jul; 43(2):271-81. PubMed ID: 17603936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p38 mitogen-activated protein kinase inhibition improves cardiac function and attenuates left ventricular remodeling following myocardial infarction in the rat.
    See F; Thomas W; Way K; Tzanidis A; Kompa A; Lewis D; Itescu S; Krum H
    J Am Coll Cardiol; 2004 Oct; 44(8):1679-89. PubMed ID: 15489104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of protein tyrosine phosphatase 1B in cardiovascular diseases.
    Thiebaut PA; Besnier M; Gomez E; Richard V
    J Mol Cell Cardiol; 2016 Dec; 101():50-57. PubMed ID: 27596049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic and pharmacological inhibition of galectin-3 prevents cardiac remodeling by interfering with myocardial fibrogenesis.
    Yu L; Ruifrok WP; Meissner M; Bos EM; van Goor H; Sanjabi B; van der Harst P; Pitt B; Goldstein IJ; Koerts JA; van Veldhuisen DJ; Bank RA; van Gilst WH; Silljé HH; de Boer RA
    Circ Heart Fail; 2013 Jan; 6(1):107-17. PubMed ID: 23230309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gelsolin regulates cardiac remodeling after myocardial infarction through DNase I-mediated apoptosis.
    Li GH; Shi Y; Chen Y; Sun M; Sader S; Maekawa Y; Arab S; Dawood F; Chen M; De Couto G; Liu Y; Fukuoka M; Yang S; Da Shi M; Kirshenbaum LA; McCulloch CA; Liu P
    Circ Res; 2009 Apr; 104(7):896-904. PubMed ID: 19246681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concentric left ventricular remodeling in endothelial nitric oxide synthase knockout mice by chronic pressure overload.
    Ruetten H; Dimmeler S; Gehring D; Ihling C; Zeiher AM
    Cardiovasc Res; 2005 Jun; 66(3):444-53. PubMed ID: 15914109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deletion of protein tyrosine phosphatase 1B rescues against myocardial anomalies in high fat diet-induced obesity: Role of AMPK-dependent autophagy.
    Kandadi MR; Panzhinskiy E; Roe ND; Nair S; Hu D; Sun A
    Biochim Biophys Acta; 2015 Feb; 1852(2):299-309. PubMed ID: 25018087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Celiprolol, a vasodilatory beta-blocker, inhibits pressure overload-induced cardiac hypertrophy and prevents the transition to heart failure via nitric oxide-dependent mechanisms in mice.
    Liao Y; Asakura M; Takashima S; Ogai A; Asano Y; Shintani Y; Minamino T; Asanuma H; Sanada S; Kim J; Kitamura S; Tomoike H; Hori M; Kitakaze M
    Circulation; 2004 Aug; 110(6):692-9. PubMed ID: 15262839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heart rate reduction induced by the if current inhibitor ivabradine improves diastolic function and attenuates cardiac tissue hypoxia.
    Fang Y; Debunne M; Vercauteren M; Brakenhielm E; Richard V; Lallemand F; Henry JP; Mulder P; Thuillez C
    J Cardiovasc Pharmacol; 2012 Mar; 59(3):260-7. PubMed ID: 22075752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complementary therapeutic effects of dual delivery of insulin-like growth factor-1 and vascular endothelial growth factor by gelatin microspheres in experimental heart failure.
    Cittadini A; Monti MG; Petrillo V; Esposito G; Imparato G; Luciani A; Urciuolo F; Bobbio E; Natale CF; Saccà L; Netti PA
    Eur J Heart Fail; 2011 Dec; 13(12):1264-74. PubMed ID: 22045926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deletion of Protein Tyrosine Phosphatase 1B (PTP1B) Enhances Endothelial Cyclooxygenase 2 Expression and Protects Mice from Type 1 Diabetes-Induced Endothelial Dysfunction.
    Herren DJ; Norman JB; Anderson R; Tremblay ML; Huby AC; Belin de Chantemèle EJ
    PLoS One; 2015; 10(5):e0126866. PubMed ID: 25974252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.